Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis

被引:5
|
作者
Orimo, Tatsuya [1 ]
Kamiyama, Toshiya [1 ]
Wakayama, Kenji [2 ]
Shimada, Shingo [1 ]
Nagatsu, Akihisa [1 ]
Asahi, Yoh [1 ]
Sakamoto, Yuzuru [1 ]
Kamachi, Hirofumi [1 ]
Taketomi, Akinobu [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido, Japan
[2] Hokkaido Prefectural Welf Federat Agr Cooperat PW, Sapporo Kosei Gen Hosp, Dept Surg, Sapporo, Hokkaido, Japan
关键词
SELECTION CRITERIA; PROGNOSTIC-FACTORS; ALPHA-FETOPROTEIN; HEPATIC RESECTION; LIVER RESECTION; 10; CM; TUMOR; SURVIVAL; RECURRENCE;
D O I
10.1245/s10434-020-08754-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We evaluated the short- and long-term surgical outcomes of hepatectomy combined with diaphragmatic resection for hepatocellular carcinoma (HCC) with diaphragmatic involvement. Methods We retrospectively reviewed the surgical outcomes of HCC patients with diaphragmatic resection (DR group) and HCC patients without diaphragmatic resection (non-DR group). We applied 1:1 propensity score matching (PSM) to these subjects. Results The study included 46 patients in DR group and 828 patients in non-DR group. The DR group cases were pathologically more advanced, and both overall and relapse-free survival among the patients in this group with pathological diaphragmatic invasion were similar to cases with pathological diaphragmatic fibrous adhesion. There were 40 patients from each group subjected to PSM. In these matched cohorts, there was no statistically significant difference between the two groups regarding perioperative outcomes, overall survival, and relapse-free survival. Multivariate analyses of our matched HCC patients revealed that alpha-fetoprotein expression and tumor size were independent prognostic factors for overall survival and poor differentiation for relapse-free survival, whereas neither diaphragmatic invasion nor diaphragmatic resection were prognostic indicators. The most frequent site of recurrence in non-DR group was the liver, whereas the most frequent site of recurrence in DR group was the lung before and after PSM. Conclusions The short- and long-term surgical outcomes of DR HCC cases are equivalent to their non-DR counterparts under a matched clinicopathological background. Hepatectomy combined with DR is an acceptable treatment for HCC with either diaphragmatic fibrous adhesion or diaphragmatic invasion.
引用
收藏
页码:4153 / 4163
页数:11
相关论文
共 50 条
  • [41] Hepatic Resection vs Particle Therapy as an Initial Treatment for Single Hepatocellular Carcinoma: Bi-institutional Propensity Score-Matched Analysis
    Omiya, Satoshi
    Komatsu, Shohei
    Terashima, Kazuki
    Yamasaki, Nobuaki
    Matsuo, Yoshiro
    Toyama, Hirochika
    Tokumaru, Sunao
    Okimoto, Tomoaki
    Fukumoto, Takumi
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (05) : 972 - 981
  • [42] Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
    Bogdanovic, A.
    Bulajic, P.
    Masulovic, D.
    Bidzic, N.
    Zivanovic, M.
    Galun, D.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Minimally invasive versus open liver resection for hepatocellular carcinoma in the elderly: international multicentre propensity score-matched study
    Sijberden, Jasper P.
    Cipriani, Federica
    Lanari, Jacopo
    Russolillo, Nadia
    Cacciaguerra, Andrea Benedetti
    Osei-Bordom, Daniel
    Conci, Simone
    Gorgec, Burak
    Primrose, John N.
    Edwin, Bjorn
    Lopez-Ben, Santi
    D'Hondt, Mathieu
    Rotellar, Fernando
    Besselink, Marc G.
    Dagher, Ibrahim
    Giuliante, Felice
    Fuks, David
    Rozzini, Renzo
    Ruzzenente, Andrea
    Sutcliffe, Robert P.
    Vivarelli, Marco
    Ferrero, Alessandro
    Cillo, Umberto
    Aldrighetti, Luca A.
    Abu Hilal, Mohammad
    BRITISH JOURNAL OF SURGERY, 2023, 110 (08) : 927 - 930
  • [44] Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study
    Zheng, Junhao
    Feng, Xu
    Liang, Yuelong
    Cai, Jingwei
    Shi, Zhaoqi
    Kirih, Mubarak Ali
    Tao, Liye
    Liang, Xiao
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (07): : 3267 - 3278
  • [45] Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study
    Li, He
    Meng, Lingzhan
    Yu, Simiao
    Zheng, Haocheng
    Yu, Lingxiang
    Wang, Hongbo
    Ren, Hui
    Li, Hu
    Zhang, Xiaofeng
    Wang, Zizheng
    Yu, Peng
    Hu, Xiongwei
    Yang, Muyi
    Yan, Jin
    Shao, Yanling
    Cao, Li
    Ding, Xia
    Hong, Zhixian
    Zhu, Zhenyu
    HEPATOLOGY INTERNATIONAL, 2024, 18 (04) : 1271 - 1285
  • [46] Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study
    Shi-Ye Yang
    Jin-Kai Feng
    Mao-Lin Yan
    Lei Guo
    Yun-Fei Duan
    Jia-Zhou Ye
    Zong-Han Liu
    Yan-Jun Xiang
    Li Xu
    Jie Xue
    Jie Shi
    Wan Yee Lau
    Shu-Qun Cheng
    Wei-Xing Guo
    Hepatology International, 2023, 17 : 1251 - 1264
  • [47] Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study
    Junhao Zheng
    Xu Feng
    Yuelong Liang
    Jingwei Cai
    Zhaoqi Shi
    Mubarak Ali Kirih
    Liye Tao
    Xiao Liang
    Surgical Endoscopy, 2021, 35 : 3267 - 3278
  • [48] Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study
    Yang, Shi-Ye
    Feng, Jin-Kai
    Yan, Mao-Lin
    Guo, Lei
    Duan, Yun-Fei
    Ye, Jia-Zhou
    Liu, Zong-Han
    Xiang, Yan-Jun
    Xu, Li
    Xue, Jie
    Shi, Jie
    Lau, Wan Yee
    Cheng, Shu-Qun
    Guo, Wei-Xing
    HEPATOLOGY INTERNATIONAL, 2023, 17 (05) : 1251 - 1264
  • [49] Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis
    Yaohong Wen
    Shuyi Zhou
    Yuyan Xu
    Cheng Zhang
    Zhoubin Feng
    Yinghui Song
    Bai Ding
    Chuang Peng
    Hongkun Tan
    Chunming Wang
    Jianan Feng
    Jingyuan Pei
    Guolin He
    Shunjun Fu
    Lvhuan Wang
    Lei Cai
    Sulai Liu
    Mingxin Pan
    World Journal of Surgical Oncology, 23 (1)
  • [50] Propensity Score-Matched Analysis Comparing Robotic and Laparoscopic Right and Extended Right Hepatectomy
    Chong, Charing C.
    Fuks, David
    Lee, Kit-Fai
    Zhao, Joseph J.
    Choi, Gi Hong
    Sucandy, Iswanto
    Chiow, Adrian K. H.
    Marino, Marco, V
    Gastaca, Mikel
    Wang, Xiaoying
    Lee, Jae Hoon
    Efanov, Mikhail
    Kingham, T. Peter
    D'Hondt, Mathieu
    Troisi, Roberto, I
    Choi, Sung-Hoon
    Sutcliffe, Robert P.
    Chan, Chung-Yip
    Lai, Eric C. H.
    Park, James O.
    Di Benedetto, Fabrizio
    Rotellar, Fernando
    Sugioka, Atsushi
    Coelho, Fabricio Ferreira
    Ferrero, Alessandro
    Tran Cong Duy Long
    Lim, Chetana
    Scatton, Olivier
    Liu, Qu
    Schmelzle, Moritz
    Pratschke, Johann
    Cheung, Tan-To
    Liu, Rong
    Han, Ho-Seong
    Chung Ngai Tang
    Goh, Brian K. P.
    JAMA SURGERY, 2022, 157 (05) : 436 - 444